𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ganciclovir prophylaxis delays but does not prevent cytomegalovirus infection in renal transplant recipients

✍ Scribed by A. Israni; K. Krok; D. Cohen; E. Blumberg; R.D. Bloom


Book ID
116930512
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
116 KB
Volume
36
Category
Article
ISSN
0041-1345

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Detection of ganciclovir resistance afte
✍ S. Alain; S. Hantz; C. Scieux; A. Karras; M.C. Mazeron; J.C. Szelag; B.M. Imbert πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 147 KB

## Abstract Whether valaciclovir (VCV) prophylaxis could be responsible for ganciclovir (GCV)‐resistance of __Human cytomegalovirus__ (HCMV) in transplantation has never been documented. A multicentric retrospective pilot study was undertaken to detect GCV‐resistance through mutations within the __

Increased incidence of cytomegalovirus i
✍ Kevin T. Shiley; Leanne B. Gasink; Todd D. Barton; Patrice Pfeiffenberger; Kim M πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 83 KB πŸ‘ 1 views

Optimal measures for the prevention of cytomegalovirus (CMV) in high-risk orthotopic liver transplant (OLT) patients are unknown. The charts of high-risk OLT recipients with 12 months of follow-up who were transplanted over a 44-month period were reviewed. The incidence of CMV disease in CMV-seropos